What has been updated
The federal Department of Health, Disability and Ageing has registered an amendment to the rules governing the Highly Specialised Drugs Program under the PBS. The instrument is the National Health (Highly Specialised Drugs Program) Special Arrangement Amendment (August Update) Instrument 2026, registered on 31 July 2026.
The amendment changes the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021), which is made under the National Health Act 1953. The Highly Specialised Drugs Program controls how certain complex medicines are listed and supplied under the PBS.
What the amendment covers
The source document does not specify which drug listings or conditions were added, removed, or changed in this update. The amendment instrument is already in force as of its registration date.
Where to find the details
The full amendment instrument is available at the Federal Register of Legislation: https://www.legislation.gov.au/F2026L01015. An Explanatory Statement is linked on the same page and provides a description of what was changed in this August update.
The Department of Health, Disability and Ageing can be contacted directly for clarification on how the changes apply to specific drug authorities or patient arrangements. The source document does not provide a contact number or email address.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.